Table 4. Relationship between early CSF neurodegeneration biomarker increases and the severity of cerebral vasospasm.
Vasospasm | CCSctf | NFHsmi35 | 14-3-3β | 14-3-3ζ | UCH-L1 | CCSntf | NSE | S100β |
No/Mild | 1.6 +/- 0.5 | 4.7 +/- 2.5 | 1.3 +/- 0.4 | 2.6 +/- 0.6 | 2.0 +/- 0.6 | 3.2 +/- 0.9 | 1.1 +/- 0.3 | 50 +/- 22 |
Mod/Severe | 10.7 +/- 8.4 | 3.7 +/- 0.8 | 20.6 +/- 9.7 | 17.3 +/- 12.7 | 12.9 +/- 8.9 | 17.9 +/- 6.9 | 14.7 +/- 6.8 | 350 +/- 285 |
P value | 0.22 | 0.77 | 0.04 | 0.19 | 0.17 | 0.03 | 0.04 | 0.24 |
The mean (+/- S.E.M.) peak level of each biomarker within 3 days of aneurysm rupture is depicted in relation to dichotomized severity of angiographic vasospasm.